International audience
-
January 2019 (v1)Journal articleUploaded on: December 4, 2022
-
January 31, 2019 (v1)Journal article
No description
Uploaded on: December 3, 2022 -
July 2004 (v1)Journal article
Several reports indicate that osteoclasts and B-lymphocytes share a common progenitor. This study focuses on the characterization of this bipotent progenitor from the bone marrow of the osteopetrotic oc/oc mouse, where the bipotent progenitor population is amplified, and of normal mice. INTRODUCTION: Osteoclasts have a myelomonocytic origin,...
Uploaded on: March 26, 2023 -
July 2006 (v1)Journal article
OBJECTIVE: We recently identified in the mouse bone marrow a B-lymphoid/myeloid B220+ CD11b+ progenitor population. This population is accumulated in the osteopetrotic oc/oc mouse, which suggests that it could be controlled by bone marrow factors whose expression varies in this pathologic bone environment. Among the possible factors,...
Uploaded on: March 26, 2023 -
September 2004 (v1)Journal article
Infantile malignant osteopetrosis (IMO) is a rare and lethal disease characterized by an absence of bone resorption due to inactive OCLs. Affected patients display an increased bone mass and hematological defects. The osteopetrotic oc/oc mouse displays a bone phenotype similar to the one observed in IMO patients, and the same gene, Tcirg1, is...
Uploaded on: March 26, 2023 -
July 2011 (v1)Journal article
B-cell development is dependent on the interactions between B-cell precursors and bone marrow stromal cells, but the role of osteoclasts (OCLs) in this process remains unknown. B lymphocytopenia is a characteristic of osteopetrosis, suggesting a modulation of B lymphopoiesis by OCL activity. To address this question, we first rescued OCL...
Uploaded on: December 3, 2022 -
November 23, 2011 (v1)Conference paper
International audience
Uploaded on: December 4, 2022 -
May 1, 2008 (v1)Journal article
Natural CD25(+)CD4(+) regulatory T cells (Treg) are essential for self-tolerance and for the control of T cell-mediated immune pathologies. However, the identification of Tregs in an ongoing immune response or in inflamed tissues remains elusive. Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule...
Uploaded on: December 4, 2022 -
December 15, 2008 (v1)Journal article
Finding that activated T cells control osteoclast (OCL) differentiation has revealed the importance of the interactions between immune and bone cells. Dendritic cells (DCs) are responsible for T-cell activation and share common precursors with OCLs. Here we show that DCs participate in bone resorption more directly than simply through T-cell...
Uploaded on: December 3, 2022 -
June 19, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
July 2006 (v1)Journal article
Malignant infantile osteopetrosis is a rare and lethal disease characterized by the absence of bone resorption due to inactive osteoclasts (OCLs). Among the murine models of osteopetrosis, the Tcirg1oc/oc mouse is the most resembling to the human pathology. In the majority of patients as in Tcirg1oc/oc mouse, the gene involved is the Tcirg1...
Uploaded on: March 26, 2023 -
September 2016 (v1)Journal article
Dendritic cells are major contributors to inflammatory bone destruction in human through RANKL mediation and could represent a new therapeutic target. Bone-resorbing cells, osteoclasts (OCs), and antigen-presenting cells, dendritic cells (DCs), share several features. They are derived from a common hematopoietic precursor, exhibit phagocytic...
Uploaded on: December 4, 2022 -
November 23, 2011 (v1)Conference paper
International audience
Uploaded on: December 3, 2022 -
October 20, 2017 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
January 25, 2018 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
May 13, 2020 (v1)Journal article
Bone destruction relies on interactions between bone and immune cells. Boneresorbing osteoclasts (OCLs) were recently identified as innate immune cells activating T cells toward tolerance or inflammation. Thus, pathological bone destruction not only relies on increased osteoclast differentiation, but also on the presence of inflammatory OCLs...
Uploaded on: December 4, 2022 -
January 4, 2021 (v1)Publication
Increased myelopoiesis is a hallmark of many chronic inflammatory diseases. However, the mechanisms involved in the myeloid skewing of hematopoiesis upon inflammation are still incompletely understood. Here, we identify an unexpected role of bone-resorbing osteoclasts in promoting hematopoietic stem cell (HSC) proliferation and differentiation...
Uploaded on: December 4, 2022 -
September 2012 (v1)Journal article
T-cell regulation in adipose tissue provides a link between inflammation and insulin resistance. Because of alterations in adipose tissue T-cell composition in obesity, we aimed to identify the antigen-presenting cells in adipose tissue of obese mice and patients with insulin resistance. Dendritic cells (DCs) and T cells were studied in mice...
Uploaded on: December 4, 2022 -
September 1, 2012 (v1)Journal article
T-cell regulation in adipose tissue provides a link between inflammation and insulin resistance. Because of alterations in adipose tissue T-cell composition in obesity, we aimed to identify the antigen-presenting cells in adipose tissue of obese mice and patients with insulin resistance. Dendritic cells (DCs) and T cells were studied in mice...
Uploaded on: March 10, 2024 -
January 2011 (v1)Journal article
Activation of the receptor activator of NF-κB (RANK) is a crucial step in osteoclastogenesis. Loss- and gain-of-function mutations in the Rank gene cause, respectively, osteopetrosis and several forms of extensive osteolysis. Tooth and alveolar bone alterations are associated with these pathologies but remain to be better characterized. The aim...
Uploaded on: December 3, 2022 -
September 2024 (v1)Journal article
International audience
Uploaded on: October 31, 2024 -
August 2018 (v1)Journal article
The PDF and HTML versions of the article have been updated to include the Creative Commons Attribution 4.0 International License information.
Uploaded on: December 4, 2022